Integra LifeSciences slides after lowering annual forecasts

** Integra LifeSciences IART.O shares fall 14.6% to $13.74 — lowest since May 11

** The medical equipment maker lowers FY26 revenue outlook to $1.63 bln-$1.65 bln from prior view $1.65 bln-$1.70 bln

** Cuts FY adj. EPS forecast to $2.30-$2.40 from $2.40-$2.50

** Trims Q3 revenue forecast to $410 mln-$412 mln from $410 mln-$425 mln

** Says July flooding at Cincinnati facility hurt Q3 revenue by ~$7 mln; sees $15 mln-$20 mln impact on Q4 revenue

** Expects full manufacturing to resume in Q227

** Three of 12 brokerages rate the stock "buy" or higher, seven "hold" and two "sell" or lower; median PT $19 - LSEG-compiled data

** Including session's move, stock up 10.4% YTD